3b2w
From Proteopedia
| Line 4: | Line 4: | ||
|PDB= 3b2w |SIZE=350|CAPTION= <scene name='initialview01'>3b2w</scene>, resolution 2.30Å | |PDB= 3b2w |SIZE=350|CAPTION= <scene name='initialview01'>3b2w</scene>, resolution 2.30Å | ||
|SITE= <scene name='pdbsite=AC1:9nh+Binding+Site+For+Residue+A+601'>AC1</scene> | |SITE= <scene name='pdbsite=AC1:9nh+Binding+Site+For+Residue+A+601'>AC1</scene> | ||
| - | |LIGAND= <scene name='pdbligand=9NH:'>9NH</scene> | + | |LIGAND= <scene name='pdbligand=9NH:N-[5-({[2-FLUORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)-2-METHYLPHENYL]-4-METHOXY-2-[(4-PIPERAZIN-1-YLPHENYL)AMINO]PYRIMIDINE-5-CARBOXAMIDE'>9NH</scene> |
| - | |ACTIVITY= [http://en.wikipedia.org/wiki/Non-specific_protein-tyrosine_kinase Non-specific protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.2 2.7.10.2] | + | |ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_protein-tyrosine_kinase Non-specific protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.2 2.7.10.2] </span> |
|GENE= LCK ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]) | |GENE= LCK ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]) | ||
| + | |DOMAIN= | ||
| + | |RELATEDENTRY=[[2ofv|2OFV]] | ||
| + | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3b2w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3b2w OCA], [http://www.ebi.ac.uk/pdbsum/3b2w PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=3b2w RCSB]</span> | ||
}} | }} | ||
| Line 14: | Line 17: | ||
==Overview== | ==Overview== | ||
N-3-(Phenylcarbamoyl)arylpyrimidine-5-carboxamides are a novel class of selective Lck inhibitors. This series of compounds derives its selectivity from a hydrogen bond with the gatekeeper Thr316 of the enzyme. X-ray co-crystal structural data, structure-activity relationships, and the synthesis of these inhibitors are reported herein. | N-3-(Phenylcarbamoyl)arylpyrimidine-5-carboxamides are a novel class of selective Lck inhibitors. This series of compounds derives its selectivity from a hydrogen bond with the gatekeeper Thr316 of the enzyme. X-ray co-crystal structural data, structure-activity relationships, and the synthesis of these inhibitors are reported herein. | ||
| + | |||
| + | ==Disease== | ||
| + | Known disease associated with this structure: SCID due to LCK deficiency OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=153390 153390]] | ||
==About this Structure== | ==About this Structure== | ||
| Line 24: | Line 30: | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Huang, X.]] | [[Category: Huang, X.]] | ||
| - | [[Category: 9NH]] | ||
[[Category: alternative splicing]] | [[Category: alternative splicing]] | ||
[[Category: atp-binding]] | [[Category: atp-binding]] | ||
| Line 45: | Line 50: | ||
[[Category: tyrosine-protein kinase]] | [[Category: tyrosine-protein kinase]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 05:22:33 2008'' |
Revision as of 02:22, 31 March 2008
| |||||||
| , resolution 2.30Å | |||||||
|---|---|---|---|---|---|---|---|
| Sites: | |||||||
| Ligands: | |||||||
| Gene: | LCK (Homo sapiens) | ||||||
| Activity: | Non-specific protein-tyrosine kinase, with EC number 2.7.10.2 | ||||||
| Related: | 2OFV
| ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
Crystal structure of pyrimidine amide 11 bound to Lck
Contents |
Overview
N-3-(Phenylcarbamoyl)arylpyrimidine-5-carboxamides are a novel class of selective Lck inhibitors. This series of compounds derives its selectivity from a hydrogen bond with the gatekeeper Thr316 of the enzyme. X-ray co-crystal structural data, structure-activity relationships, and the synthesis of these inhibitors are reported herein.
Disease
Known disease associated with this structure: SCID due to LCK deficiency OMIM:[153390]
About this Structure
3B2W is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR., Deak HL, Newcomb JR, Nunes JJ, Boucher C, Cheng AC, DiMauro EF, Epstein LF, Gallant P, Hodous BL, Huang X, Lee JH, Patel VF, Schneider S, Turci SM, Zhu X, Bioorg Med Chem Lett. 2008 Feb 1;18(3):1172-6. Epub 2007 Dec 5. PMID:18083554
Page seeded by OCA on Mon Mar 31 05:22:33 2008
Categories: Homo sapiens | Non-specific protein-tyrosine kinase | Single protein | Huang, X. | Alternative splicing | Atp-binding | Chromosomal rearrangement | Cytoplasm | Disease mutation | Host-virus interaction | Kinase domain | Lck | Lipoprotein | Membrane | Myristate | Nucleotide-binding | Palmitate | Phosphorylation | Proto-oncogene | Sh2 domain | Sh3 domain | Transferase | Tyrosine-protein kinase
